Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case report documents a 61-year-old woman treated with erlotinib who experienced the rare side effect of cicatricial alopecia.

In this study of postpartum alopecia, most patients experienced significant hair regrowth within four to six months, and heredity did not appear to be a significant factor in hair loss.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

This study suggests the average age of onset for androgenic alopecia may be decreasing, but a longer-term study is needed to confirm this observation.

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

This review of 1360 scalp biopsy specimens revealed that 12.5% of cases involved multifactorial alopecia, highlighting the diagnostic complexity of multiple forms of alopecia present in single biopsies.

The study found that balding scalps have more thin hairs and larger oil glands, which might contribute to skin conditions related to hair loss.

This study found that among alopecia patients, 64.5% had androgenetic alopecia, with a significant prevalence in individuals under age 30 and links to family history and androgen-associated conditions.

This study observed an increasing trend of young patients with androgenetic alopecia visiting dermatologists, with genetic factors and abnormal androgen metabolism in the scalp contributing to its development.

The researchers reported that combining platelet-rich plasma with minoxidil showed the most improvement in androgenetic alopecia compared to other treatment groups, but also had more pain as a side effect.

This study documented that discoid lupus erythematosus was the most common cause of alopecia among patients at a dermatology outpatient clinic in Nigeria from 2014 to 2019.

This observational study found that trichoscopy is a reliable tool for diagnosing various hair and scalp disorders, with common findings observed for different types of alopecia.

This study reported an increase in female androgenic alopecia patients in their forties and found stress-related factors, particularly work tasks, associated with AGA in both male and female patients.

This study reviewed current scientific evidence on how scalp microbiome alterations may affect hair growth, citing connections to inflammatory and immune processes and suggesting potential for therapeutic targeting, though further studies are needed to confirm clinical applications.

This study found that the combination of minoxidil, microneedling, and platelet-rich plasma was more effective for androgenetic alopecia than minoxidil alone, although adverse effects were noted.

This study summarizes common types of alopecia affecting many in China and suggests that factors like hormones, microorganisms, and immune dysregulation might contribute to hair loss, laying groundwork for better diagnosis and treatment approaches.

In this retrospective study of 133 pediatric patients, topical minoxidil was generally well tolerated for managing androgenetic alopecia, but close monitoring and adherence to treatment, accounting for hormonal and concurrent conditions, were emphasized for effective care.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

This case report highlights a 34-year-old woman with traction alopecia, where diagnosis was clarified by the presence of peripilar keratin sheaths, a useful dermoscopic clue.

This article presents a dermatological case involving a 36-year-old woman with ambiguous alopecia, evaluated using videodermatoscopy, but it reports no new research findings or clinical outcomes.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

This study found that high-frequency ultrasonography may effectively distinguish different stages of alopecia areata and differentiate it from other scalp conditions.

In this study conducted at a tertiary hospital, researchers found that female pattern hair loss was the most common cause of alopecia in adult female patients, followed by traction alopecia and alopecia areata, with traction alopecia notably common among Indian patients.

In this retrospective study from Jiangsu Province Hospital, researchers reported a high prevalence of pediatric androgenetic alopecia in patients under 18, often associated with hormonal imbalances and comorbid conditions, emphasizing the need for individualized treatment plans that prioritize addressing hormonal disorders and comorbidities.

This study examined 12 women with androgenetic alopecia and found that many had other symptoms linked to hyperandrogenism, suggesting the importance of further hormone level investigations.

This study found that topical application of hair lotion containing 17α-estradiol may reduce androgenetic hair loss, as 63% of treated patients showed a decrease in telogen hairs compared to 37% in the control group.

This study found that topical hair lotions with 17 alpha-estradiol may reduce telogen hair loss in patients with androgenetic alopecia, though they did not lead to new hair regrowth.

This case study reports a 66-year-old woman developing shortness of breath while taking 50 mg/day of cyproterone acetate for androgenetic alopecia, a complication not previously documented in women with this condition.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

In this study involving two volunteers with Androgenetic Alopecia, phototherapy using red and blue wavelengths promoted benefits, as observed through photographic and trichoscopy comparison after 12 weekly sessions.